Posted: August 8, 2012

Cancer education, even for medical specialists, is a challenge in a rapidly changing environment.  Dr. Stark has been invited by Oakstone Medical Publishing in cooperation with Johns Hopkins School of Medicine to serve as a reviewer for Practical Reviews in Cancer Management, an audio/CD product used by practicing oncologists to keep abreast of the latest developments in their specialty.   He will review several of the most important articles published each month, as selected by the editorial board of PRCM.  He is currently working on a review of an article published in July in the New England Journal of Medicine in which the final results of the PIVOT trial are presented.  The  most important trial ever conducted in the US on prostate cancer, PIVOT looked at the value of early intervention in prostate cancer versus watchful waiting.  The study found that only a fraction of men treated each year for prostate cancer with radical surgery, those with the most aggressive cancers, benefited from having their cancer treated early.  For the majority of men, it didn’t seem to matter whether they had their cancer treated at all.  This stunning result, not entirely expected, should have a major impact on how newly diagnosed prostate cancer is viewed.